A charming chat: Part One with UnitedHealthCare CMO on Covid 19 treatment
Channel: The Doctor Weighs In
Date: 08/06/2020

One area of Covid 19 treatment that has been successful in the past, but not leveraged as much is adoptive immunity of transferring sensitized serum to patients who are just starting to develop symptoms with the serum of patients who have overcome the disease. 

In this interview, we talk with Chief Medical Officer (CMO) of UnitedHealth Group, Dr. Migliori to discuss their collaboration with the Mayo Clinic for a clinical trial that has recruited over 27,000 patients. 

This enormous collaboration with UnitedHealthcare involves over 7,000 doctors, 2400 participating centers including John Hopkins, Mt. Sinai and several others including local community hospitals. 

This is Part One of a three part series.

You can also check out the article on thedoctorweighsin.com. To enroll now, visit: https://www.uscovidplasma.org/

Help stop the spread of the coronavirus.